StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

ENDRA Life Sciences's profit margin for the twelve months ending Dec 31, 2018 was -158669.6%. For fiscal 2018 it was -158669.6%, against -1529.2% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 2018-158669.6%−157140.4
FY2017Dec 31, 2017-1529.2%−990.9
FY2016Dec 31, 2016-538.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 2018-45761.3%−45627.7
Q4 FY2017Dec 31, 2017-33498.4%–
Q3 FY2017Sep 30, 2017-316.7%–
Q2 FY2017Jun 30, 2017-2478.3%–
Q4 FY2016Dec 31, 2016-133.6%–

More ENDRA Life Sciences figures

See a number that looks wrong?